Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Hims & Hers Health, Inc. Class A Common Stock (NY:HIMS)

19.73 -1.08 (-5.19%)
Official Closing Price Updated: 7:00 PM EST, Nov 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Hims & Hers Health, Inc. Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
64 65 Next >
News headline image
Hims & Hers Bounced Back 9%, But Its Earnings Reveal a Costly Trade-Off ↗
Hims & Hers stock sank after a Q3 earnings and revenue miss, lower EBITDA guidance, subscriber declines, and an expanding FTC lawsuit over privacy and billing practices. 
Via MarketBeat
Topics Earnings Lawsuit
News headline image
A $400 Billion Healthcare Opportunity: Telehealth Companies Positioned to Capitalize on a Massive Industry Shift
Healthcare Innovation and Technology Adoption Are Reshaping How Millions of Patients Access Medical Services 
From FN Media
Via GlobeNewswire
News headline image
A $400 Billion Healthcare Opportunity: Telehealth Companies Positioned to Capitalize on a Massive Industry Shift
EQNX::TICKER_START (OTCQB:AIRDF),(CSE:AIDR),(NYSE:TDOC),(NYSE:AMWL),(NYSE:HIMS),(NYSE:DOCS) EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Artificial Intelligence
News headline image
Why Hims & Hers Health (HIMS) shares are getting obliterated today
What happened? Shares of telehealth company Hims & Hers Health (NYSE:HIMS) fell 18.5% in the afternoon session after the company reported its financial resul... 
Via StockStory
News headline image
Hims & Hers: 3 Key Takeaways for Long-Term Investors ↗
Management is betting that a lighter marketing push now sets Hims & Hers up for the January weight-loss surge, but it's unclear whether lost subscribers will return. 
Via The Motley Fool
Topics Earnings
Stock Market Today: Nvidia Board Opens Probe Into Jensen Huang as Wall Street Licks Its AI Wounds ↗
Via Chartmill
Topics Artificial Intelligence
News headline image
Hims & Hers (HIMS) Q3 2026 Earnings Call Transcript ↗
International expansion offset a U.S. subscriber slowdown in the quarter. 
Via The Motley Fool
Topics Earnings
News headline image
HIMS Q3 2026 deep dive: cautious marketing spend and product launches shape guidance
Telehealth company Hims & Hers Health (NYSE:HIMS) met Wall Street’s revenue expectations in Q3 2026, with sales up 48.6% year on year to $890.4 million. On t... 
Via StockStory
News headline image
What Hims & Hers Health (HIMS) Said on Its Q3 Earnings Call ↗
Hims & Hers Health (NYSE:HIMS) reported third-quarter revenue growth of 49% but lost 100,000 subscribers from the prior quarter, as the digital health company held back U.S. weight-loss marketing and... 
Via MarketBeat
Topics Earnings
News headline image
Hims & Hers Health (NYSE:HIMS) posts Q3 2026 sales in line with estimates but full-year sales guidance misses expectations
Telehealth company Hims & Hers Health (NYSE:HIMS) met Wall Street’s revenue expectations in Q3 2026, with revenue up 48.6% year on year to $890.4 million. On... 
Via StockStory
News headline image
Dr. Andrew Huberman Joins Hims & Hers Board of Directors
From Hims & Hers
Via Business Wire
News headline image
Hims & Hers Health, Inc. Reports Third Quarter 2026 Financial Results
From Hims & Hers
Via Business Wire
News headline image
Hims & Hers Health earnings: what to look for from HIMS
Telehealth company Hims & Hers Health (NYSE:HIMS) will be reporting earnings this Monday after market close. Here’s what you need to know. Hims & Hers Health... 
Via StockStory
Topics Artificial Intelligence
News headline image
Hims & Hers Health vs. Intuitive Surgical: Which Healthcare Stock Is a Better Buy for 2027? ↗
Both are disruptors, but one of these growth stocks stands out over the other. 
Via The Motley Fool
News headline image
Lilly and Hims & Hers expand access to FDA-approved Lilly medicines
From Hims & Hers
Via Business Wire
News headline image
Could the Midterms Revive Medicare for All? 3 Healthcare Stocks to Watch ↗
Via MarketBeat
News headline image
Federal Peptide Policy Shift Could Ignite a New Wave Of Growth Across the $164 Billion Peptide Market
New HHS Direction Creates Potential Opportunities for Peptide Manufacturers, Biotech Companies, and Healthcare Innovators 
From FN Media
Via GlobeNewswire
News headline image
Federal Peptide Policy Shift Could Ignite a New Wave Of Growth Across The $164 Billion Peptide Market
EQNX::TICKER_START (OTCQB:PNGAF),(CSE:BPC),(NASDAQ:MBX),(NASDAQ:KLRA),(NASDAQ:ALT),(NYSE:HIMS) EQNX::TICKER_END 
Via FinancialNewsMedia
News headline image
Hims & Hers Benefits Adds Grüns, Medjet, Tonal, and Viome for Whole-Body Health and Support When You Need It Most
From Hims & Hers
Via Business Wire
News headline image
Hims & Hers Health, RadNet, and Henry Schein shares are soaring, what you need to know
What happened? A number of stocks jumped in the afternoon session after election results confirmed that Democrats reclaimed majorities in the House and Senat... 
Via StockStory
Topics Economy
News headline image
CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Hims (NYSE: HIMS) Investors of Securities Class Action Lawsuit Deadline on November 2, 2026
From Faruqi & Faruqi, LLP
Via Business Wire
News headline image
HIMS Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit with SBS Law
From Schall, Brown & Schwartz LLP
Via Business Wire
News headline image
HIMS DEADLINE MONDAY: Bragar Eagel & Squire, P.C. Urges Hims & Hers Health, Inc. Investors to Contact the Firm Before November 2nd
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Hims & Hers Health 72 Hour Deadline Alert: Kahn Swick & Foti, LLC Reminds Investors With Losses In Excess Of $100,000 of Deadline in Class Action Lawsuit Against Hims & Hers Health, Inc. - HIMS
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
Kaplan Fox Urges Investors of Hims & Hers Health, Inc. (NYSE: HIMS) to Contact the Firm Before the Securities Class Action Deadline on November 2, 2026
From Kaplan Fox & Kilsheimer, LLP
Via GlobeNewswire
News headline image
Hims & Hers Health Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Hims & Hers Health, Inc. - HIMS
From SkyMedia, LLC
Via GlobeNewswire
News headline image
Kaplan Fox Encourages Hims & Hers Health, Inc. (NYSE: HIMS) Investors to Learn About the Securities Class Action Ahead of the November 2, 2026 Deadline
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
News headline image
HIMS Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit with SBS Law
From Schall, Brown & Schwartz LLP
Via GlobeNewswire
News headline image
The $294 Billion Peptide Boom: Biotech Companies Positioned for the Next Wave of Growth
Breakthroughs in obesity, diabetes, oncology, and targeted therapies are driving fresh interest in peptide-based medicines and the companies developing the next generation of treatments. 
From FN Media
Via GlobeNewswire
News headline image
The $294 Billion Peptide Boom: Biotech Companies Positioned for the Next Wave of Growth
EQNX::TICKER_START (OTCQB:PNGAF),(CSE:BPC),(NYSE:NVO),(NYSE:HIMS),(NYSE:ENHA),(NYSE:LLY) EQNX::TICKER_END 
Via FinancialNewsMedia
< Previous 1 2 3 4 5 6 7 8 9
...
64 65 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.